FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
$3.65
-0.160 (-4.20%)
At Close: May 31, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development al... EPRX.TO Profile

Golden Star

Ticker Date Change Price
OXM May 29 3.64% $106.80
UTZ May 29 2.43% $18.10
DVAX May 29 3.99% $11.53
GNTX May 28 1.66% $34.43
OHI May 20 4.76% $30.86
CNI May 16 0.600% $126.57
TTWO May 16 9.78% $146.08
RL May 15 11.92% $166.98
LNG May 14 0.235% $157.42
VCLT May 14 0.277% $75.73
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT